GPC3 and breast cancer: P38 MAPK pathway: In breast cancer cells, GPC3 has been shown to reverse the EMT, prevent metastatic spread, and induce dormancy at secondary sites by activating the p38 mitogen-activated protein kinase (MAPK) pathway [110].